In patients with heart failure with preserved ejection fraction (HFpEF) and chronotropic incompetence, indexed left ventricular systolic volume (iLVESV) may predict those who could benefit most from ...

The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...

Please provide your email address to receive an email when new articles are posted on . Beta-blocker discontinuation 1 year after acute MI was noninferior to continuation in stable patients without HF ...

LONDON -- Heart attack survivors who were expected to be fine after going off their beta-blockers fared worse clinically compared with those who continued them, a randomized trial showed. After years ...

Beta-blockers are excellent drugs. They're cheap and effective; feature prominently in hypertension guidelines; and remain a sine qua non for coronary artery disease, myocardial infarction, and heart ...

A drug commonly prescribed after a heart attack doesn’t seem to offer significant benefits for people who recover without lasting damage — and could pose added risks to women. In a new research trial, ...